Four intelligence briefsBiotech & Pharma · AI & Technology · Worldview · Life

Mind Clubpunitdhillon.com/mindclub · @PDMC_x

Four intelligence briefs covering biotech, AI and technology, global affairs and life. Key claims linked to sources, counterarguments made explicit, forecasts tracked publicly, and corrections recorded.

Choose your briefs See the sources

Signal > NoiseImplications > HeadlinesPrimary sources > Commentary

Human-led · Source-checked

The record so farEvery published edition · to Mon 11.02.2026

The number · Sources verified

364

unique sources behind the Claim Check verdicts in every published edition, each one linked and dated. Two editions citing the same source count once.

From 383 citations in every published edition

Registries · filings · dockets · journals · data releases

Each square is one source · Filled: verified against the claim it backs

We show a Brier score once a brief has 20 graded forecasts. That's a floor for showing a number, not proof of accuracy or calibration: early scores can swing a lot, and a few dozen forecasts say little about the next one. A Brier score measures how close forecasts came to what happened: for each one, take the probability we gave, subtract the outcome (1 if it happened, 0 if not) and square it, then average. Lower is better. Zero is perfect, and calling every forecast 50% scores 0.25. Every number links to the edition or ledger behind it. Track records: Biotech, AI, Worldview.

01  The briefs

Choose one, or all four.

Mind Club is the club. Each brief comes to you by email from its own home, which has a site and an X account.

How Mind Club works

Daily or weekly

Biotech & PharmaIntelligence

Biotech Signal · pdmc.bio@PDMC_bio Science

What happened in biotech, what the evidence supports, and what to watch next.

Latest · Ed. 036

Inside

  • Five things to know, each with a red team
  • Claim Check: readouts against the registered trial
  • Target Evidence Card: the day's lead target, from genetics to who's developing on the science
Included Biotech Signal Capital momentum by therapeutic area, and trial catalysts graded A to F Open Biotech Signal

Emails from

Biotech Signal · Biotech & Pharma

How often
Daily or weekly

AI & TechnologyIntelligence

AI Observatory · pdmc.ai@PDMC_ai Business

What AI can actually do, what changed, what it costs and where it fails.

Latest · Ed. 036

Inside

  • Five things to know
  • The Decoder: AI jargon in plain English
  • What you can use today, with sandbox experiments
  • Frontier AI, agents and scientific AI
  • AI x biotech reality check
On the record Forecast ledger Every call, graded in public. Misses first. See the ledger

Emails from

AI Observatory · AI & Technology

How often
Weekly · Saturday

WorldviewIntelligence

World Atlas · pdmc.world@PDMC_world Humanity

How the world changed this week, who can move it, and what would change the outlook.

Latest · Ed. 007

Inside

  • The world in 5 minutes
  • The view from elsewhere
  • Follow the power
  • Red Team / Blue Team
  • Forecasting lab, scored in public
On the record Forecast ledger Every call, graded in public. Misses first. See the ledger

Emails from

World Atlas · Worldview

How often

One edition, Saturdays

Delayed gratification

LifeIntelligence

Elsewhere · pdmc.life@PDMC_life Life

What's worth your time, and where to start. Published when it's ready, not before.

Latest · Ed. 001
Glasgow's walkers sued their way through the wall Read Life Intelligence, Glasgow's walkers sued their way through the wall · PDF

Inside

  • Doors: a few things worth your time
  • The Detour: one longer story
  • Myth Check: one thing everyone repeats
  • Taste, and the Quiz
Included Elsewhere The good finds, kept for when you're ready Take a detour

Emails from

Elsewhere · Life

How often

Open the shelfEvery edition, for subscribers. Your link is in any Mind Club email.

02  Join

Request early access to Mind Club.

Choose your briefs and, where there's a choice, how often. Access is complimentary, including Biotech Signal with either biotech subscription option, and Elsewhere with Life.

No briefs selected yet

Change your briefs

We review access requests. If approved, you'll receive an email to confirm your subscription.

You'll only get the briefs you picked, and you can unsubscribe from any of them at any time. No company we cover pays us, and we never sell or share your address. By requesting access you agree to the Terms of Use and the Privacy policy.

If plans change. We may introduce paid plans as Mind Club develops. If we do, you'll hear from us first, and moving to a paid plan will always be your choice.

Access is limited for now. We keep your request (name, email, briefs and note) for up to 365 days, then delete it.

03  Why trust it?

Because you can check it.

It shows where it looked

Registries, filings, dockets, journals and data releases, linked and dated, so you can read what the brief read.

It shows its work

Key claims carry a label and a source: the document, the passage and a verdict. Partial and open verdicts get printed too.

It keeps score

Forecasts carry odds and a date, and get graded in public. Misses come first.

How it's made An AI system and workflow using expert agents writes every brief, working from editorial rules that set what to cover, which sources to trust and how to check a fact. An editor approves every edition before it's sent. Approval isn't a line-by-line check, so mistakes will get through. That's what the sources are for.

Why we built it The Architecture of Signal, the essay on holding machine-assisted analysis to its sources.

Why the name The name dates to 2020, when a few friends got talking about the causes they cared about. It's a club because you can ask, correct and check the record. Read why

04  Proof of work

Straight from the latest briefs.

One matched claim from each brief, as published. The record above counts every verdict, partial and open ones included, and each row links to its full table.

Claim Check sets a claim beside the evidence, such as the endpoint in the trial registry, and records what the evidence supports and what's still unresolved. A verdict covers that one claim. It isn't a quality score for the study or proof that a treatment works.

Claim CheckOne match from each brief

Biotech & Pharma IntelligenceEdition 036 · 11.02

Registry says
Phase 2/3, two stages under one protocol. Primary: percent change in CLASI-A from baseline to week 24, and CLASI-70 response at week 24. N=390. Recruiting, start 10.2026.
Headline says
About 390 adults, Phase 2/3, primary CLASI-A percent change at week 24

Match

AI & Technology IntelligenceEdition 036 · 11.02

Primary document says
Implied enterprise value about $115B; 4.500 shares per share; 23.9% premium to the 10.28 close
Headline says
$115 billion merger

Match

Worldview IntelligenceEdition 006 · 10.31

Claim
10,193 confirmed cases and 4,960 deaths in Congo (data to 10.27)
The passage
“10 193 confirmed cases, including 4 960 related deaths (from data up until 27 October)”

Match

Red Team / Blue TeamWorldview · Edition 002 · 10.03.2026

The proposition

Governments should freeze evictions of vulnerable tenants who have nowhere else to go until the housing shortage eases, as Spain's rejected decree would have done until 2030.

Blue team defends · Kautilya, Arthashastra

A state that lets its people fall into ruin weakens itself. An 87-year-old evicted with nowhere to go is the kind of visible ruin a competent state prevents.

Best evidence: in 2024, 28.1% of Spain's market-rate renters spent over 40% of disposable income on housing, against 19.2% across the EU. Fact

Red team attacks · Hayek, The Use of Knowledge in Society

Prices carry knowledge no planner has; when the state overrides them, people respond in ways it can't foresee. A four-year freeze tells owners to rent less.

Best evidence: in San Francisco, landlords whose buildings came under rent control cut the rental housing they supplied by 15% (American Economic Review, 2019). Fact

Where they really disagree Which margin counts: the tenant in front of us now, or the future tenant who never finds a flat. We don't pick a winner.

Ask Mind Club

Ask a question. We answer one a week across the briefs, with sources.

Something in a brief you want unpacked, or a question you think we should be asking? Send it in. We pick one each week and answer it in the brief.

Questions stay private unless we pick one, and your name appears only if you tick the box. If you leave an email, we use it once to tell you the answer is out, then delete it. Unanswered questions are deleted after 180 days. Privacy policy.